Inna M. Chen

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Journal: Journal for immunotherapy of cancer

Published: June 29, 2026

What matters most early in the cancer trajectory: patient concerns and priorities in pancreatic and lung cancer (BetterEveryDay trial).

What matters most early in the cancer trajectory: patient concerns and priorities in pancreatic and lung cancer (BetterEveryDay trial).

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: February 26, 2026

Corrigendum to "Study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay)" [Eur. J. Oncol. Nurs. 76C [2025] 102898].

Corrigendum to "Study of a supportive application with integrated patient-reported outcomes in patients with advanced pancreatic or lung cancer (BetterEveryDay)" [Eur. J. Oncol. Nurs. 76C [2025] 102898].

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: February 05, 2026

Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.

Extracellular matrix biomarkers of T-cell infiltration and tumor fibrosis predict response to nivolumab ± ipilimumab with SBRT in biliary tract cancer: insights from the CheckPAC trial.

Journal: BMC medicine

Published: February 04, 2026

Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Journal: Signal transduction and targeted therapy

Published: September 09, 2025

Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 23, 2025

Symptom burden and quality of life in patients with pancreatic and peri-pancreatic cancer at admission to specialized palliative care: a nationwide register-based study in Denmark.

Symptom burden and quality of life in patients with pancreatic and peri-pancreatic cancer at admission to specialized palliative care: a nationwide register-based study in Denmark.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: July 11, 2025

BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target.

BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target.

Journal: Scientific reports

Published: July 08, 2025

Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis.

Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis.

Journal: Cancer treatment reviews

Published: June 19, 2025

A phase II study of nivolumab, ipilimumab, and radiation in combination with influenza vaccine in patients with pancreatic cancer (INFLUENCE).

A phase II study of nivolumab, ipilimumab, and radiation in combination with influenza vaccine in patients with pancreatic cancer (INFLUENCE).

Journal: Immuno-oncology technology

Published: June 06, 2025

Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer.

Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer.

Journal: Science advances

Published: May 21, 2025

Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer.

Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 21, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026